Conversely, CCR6+ T cells in the lungs of IPF subjects were decreased (7.43%; range, 3.74–12.10%) in comparison to controls (15.00%; range, 0.98–34.80%; p = 0.003). This evidence concerns the gene CCR6 and idiopathic pulmonary fibrosis.